Abstract:Over the course of the human lifespan, somatic DNA mutations accumulate in healthy tissues. This process has been most clearly described in blood and bone marrow, esophagus, colon and skin, but cumulative DNA damage likely affects all tissues of the body. While most acquired genetic variants have no discernable functional consequences, some randomly occurring somatic mutations confer a relative fitness advantage on a single stem cell and its progeny compared to surrounding cells, which may lead to progressive expansion of a clone (i.e., a genetically identical group of cells). When these mutations occur in a cell with the capacity to self-renew and expand, the mutations persist, and such clonal expansion is a risk factor for further mutation acquisition and clonal evolution.Hematopoietic stem cells are a special case of clonal expansion, because both the stem cells and their blood cell progeny circulate in large numbers, and these cells are not subject to some of the anatomical restrictions that characterize other tissues in which somatic mutations conferring a fitness advantage also occur. Therefore, clonally restricted hematopoiesis can have biological and clinical consequences that are distinct from clonal expansions in other tissues. Such consequences include not just clonal progression to overt myeloid neoplasia (or, less commonly, to lymphoid neoplasia) driven by acquisition of secondary mutations in the cells of the expanded clone, but also cardiovascular events, as described further below – and most likely other diseases that are influenced by aberrant function of mutant blood cells.If we can understand in more detail how clonal hematopoiesis arises and how clonal selection and expansion occur, as well as develop strategies to avert the clinical consequences associated with clonal hematopoiesis, this may both improve public health and yield more general insights into the biology of aging.

Dynamics of clonal hematopoiesis and risk of hematologic malignancy

Clonal hematopoiesis: Pre-cancer PLUS

Clonal hematopoiesis and hematological malignancy

The longitudinal dynamics and natural history of clonal haematopoiesis

Clonal hematopoiesis as a model for premalignant changes during aging

Decoding Clonal Hematopoiesis: Emerging Themes and Novel Mechanistic Insights

Clonal hematopoiesis: Molecular and clinical implications

Implications of Clonal Hematopoiesis in Hematological and Non-Hematological Disorders

Clinical and Therapeutic Implications of Clonal Hematopoiesis

Progressive disruption of hematopoietic architecture from clonal hematopoiesis to MDS.

The evolutionary dynamics and fitness landscape of clonal hematopoiesis

Epigenetic and proteomic signatures associate with clonal hematopoiesis expansion rate

Clonal hematopoiesis and atherosclerosis

Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies

Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis

Clonal hematopoiesis of indeterminate potential: the root cause of, and fertile ground for, hematological malignancies

Clonal hematopoiesis in human aging and disease

Clonal dominance and transplantation dynamics in hematopoietic stem cell compartments

Analysis of somatic mutations in whole blood from 200,618 individuals identifies pervasive positive selection and novel drivers of clonal hematopoiesis

Shared and distinct genetic etiologies for different types of clonal hematopoiesis

Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects